Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q3 Loss of 15c/Share
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $3.58 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
